<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Shanghai Arch Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Shanghai Arch Psychiatry</journal-id><journal-id journal-id-type="publisher-id">SAP</journal-id><journal-title-group><journal-title>Shanghai Archives of Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">1002-0829</issn><publisher><publisher-name>Shanghai Municipal Bureau of Publishing</publisher-name><publisher-loc>Shanghai, China</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25477720</article-id><article-id pub-id-type="pmc">4248259</article-id><article-id pub-id-type="publisher-id">sap-26-05-272</article-id><article-id pub-id-type="doi">10.11919/j.issn.1002-0829.214067</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Randomized controlled trial of adjunctive EEG-biofeedback 
treatment of obsessive-compulsive disorder </article-title><trans-title-group xml:lang="zh"><trans-title>&#x08111;&#x07535;&#x0751f;&#x07269;&#x053cd;&#x09988;&#x08f85;&#x052a9;&#x06cbb;&#x07597;&#x05f3a;&#x08feb;&#x075c7;&#x07684;&#x0968f;&#x0673a;&#x05bf9;&#x07167;&#x08bd5;&#x09a8c;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Xiaopeng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="bio" rid="d35e38">*</xref></contrib><contrib contrib-type="author"><name><surname>WANG</surname><given-names>Gaohua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>ZHOU</surname><given-names>Lifang</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>ZHANG</surname><given-names>Xinfeng</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>YANG</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>HAN</surname><given-names>Gangya</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>TU</surname><given-names>Zheming</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>LIU</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><aff id="aff1"><sup>1</sup>Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China</aff><aff id="aff2"><sup>2</sup>Jingzhou Mental Health Center, Jingzhou, Hubei Province, China</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>correspondence: <email>jzxlys@163.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2014</year></pub-date><volume>26</volume><issue>5</issue><fpage>272</fpage><lpage>279</lpage><history><date date-type="received"><day>19</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>07</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 by Shanghai Municipal Bureau of Publishing</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/"><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link></license-p></license></permissions><abstract><sec id="s1"><title>Background</title><p>Current interventions for obsessive-compulsive disorder (OCD) are often of limited benefit.
Aim:To evaluate the effect of adjunctive treatment with EEG biofeedback training on the symptoms and 
cognitive functioning of individuals with OCD. </p></sec><sec id="s2"><title>Aim</title><p>To evaluate the effect of adjunctive treatment with EEG biofeedback training on the symptoms and 
cognitive functioning of individuals with OCD. </p></sec><sec id="s3"><title>Methods</title><p>A total of 79 individuals with OCD were randomly assigned to the study group (n=40) or the 
control group (n=39). The control group was treated using a combination of sertraline (50 to 200 mg/d) 
and weekly cognitive behavioral therapy sessions by trained therapists for 8 weeks; the study group was 
treated using the same regimen plus EEG biofeedback sessions 5 times per week. The Yale Brown Obsessive 
Compulsive Scale (YBOCS) was administered by a psychiatrist who was blind to patients&#x02019; treatment status 
before treatment and at the end of the 2<sup>nd</sup>, 4<sup>th</sup>, 6<sup>th</sup> and 8<sup>th</sup> week for treatment; the Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS) was administered before and after the 8-week trial.</p></sec><sec id="s4"><title>Results</title><p>Three individuals dropped out of the study group and four dropped out of the control group 
(<italic>&#x003c7;</italic><sup>2</sup>=0.186, <italic>p</italic>=0.712). At the end of the study, treatment was considered effective in 32 of the 37 (86.5%) 
participants in the study group and in 22 of the 35 (62.9%) participants in the control group (<italic>&#x003c7;</italic><sup>2</sup>=5.36, 
<italic>p</italic>=0.021). Repeated measures analysis of variance showed that the improvement in OCD symptoms was 
greater in the study group than the control group by the 6<sup>th</sup> week of treatment. At the end of the trial all 
5 cognitive dimensions assessed by the RBANS were significantly better in study groups subjects than in 
control group subjects and the changes in the YBOCS score were significantly correlated with changes in the 
RBANS overall score in the study group (<italic>r</italic>=0.43, <italic>p</italic>=0.007), but not in the control group (<italic>r</italic>=0.171, <italic>p</italic>=0.327).</p></sec><sec id="s5"><title>Conclusions</title><p>This methodologically rigorous study demonstrates that 8 weeks of adjunctive treatment with 
EEG biofeedback training can significantly improve the clinical symptoms and cognitive functioning of OCD 
patients being treated with medication and psychotherapy. Further work is needed to assess the long-term 
effects of biofeedback training and the need for booster sessions after an initial period of training.</p></sec></abstract><trans-abstract xml:lang="zh"><sec><title>&#x080cc;&#x0666f;</title><p>&#x076ee;&#x0524d;&#x05bf9;&#x05f3a;&#x08feb;&#x075c7;&#x0ff08;OCD&#x0ff09;&#x07684;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x05f80;&#x05f80;&#x07597;&#x06548;&#x06709;&#x09650;&#x03002;</p></sec><sec><title>&#x076ee;&#x07684;</title><p>&#x08bc4;&#x04ef7;&#x08111;&#x07535;&#x0751f;&#x07269;&#x053cd;&#x09988;&#x08bad;&#x07ec3;&#x04f5c;&#x04e3a;&#x05f3a;&#x08feb;&#x075c7;&#x060a3;&#x08005;&#x075c7;&#x072b6;&#x0548c;
&#x08ba4;&#x077e5;&#x0529f;&#x080fd;&#x08f85;&#x052a9;&#x06cbb;&#x07597;&#x07684;&#x06548;&#x0679c;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x05171;79&#x0540d;&#x05f3a;&#x08feb;&#x075c7;&#x060a3;&#x08005;&#x0968f;&#x0673a;&#x05206;&#x04e3a;&#x07814;&#x07a76;&#x07ec4;&#x0ff08;n=40&#x0ff09;&#x0548c;
&#x05bf9;&#x07167;&#x07ec4;&#x0ff08;n=39&#x0ff09;&#x03002;&#x05bf9;&#x07167;&#x07ec4;&#x0670d;&#x07528;&#x0820d;&#x066f2;&#x06797;&#x0ff08;50~200mg/d&#x0ff09;
&#x05408;&#x05e76;&#x06bcf;&#x05468;&#x04e00;&#x06b21;&#x03001;&#x08fde;&#x07eed;8&#x05468;&#x07684;&#x08ba4;&#x077e5;&#x0884c;&#x04e3a;&#x06cbb;&#x07597;&#x0ff1b;&#x07814;&#x07a76;&#x07ec4;&#x091c7;
&#x07528;&#x076f8;&#x0540c;&#x07684;&#x065b9;&#x06848;&#x0518d;&#x052a0;&#x04e0a;&#x08111;&#x07535;&#x0751f;&#x07269;&#x053cd;&#x09988;&#x08bad;&#x07ec3;&#x0ff0c;&#x06bcf;&#x05468;5&#x06b21;&#x03002;
&#x07531;&#x04e00;&#x04f4d;&#x05355;&#x076f2;&#x04e8e;&#x060a3;&#x08005;&#x06cbb;&#x07597;&#x072b6;&#x06001;&#x07684;&#x07cbe;&#x0795e;&#x079d1;&#x0533b;&#x05e08;&#x05206;&#x0522b;&#x05728;&#x06cbb;&#x07597;
&#x0524d;&#x0548c;&#x06cbb;&#x07597;&#x07b2c;2&#x05468;&#x0672b;&#x03001;&#x07b2c;4&#x05468;&#x0672b;&#x03001;&#x07b2c;6&#x05468;&#x0672b;&#x0548c;&#x07b2c;8&#x05468;&#x0672b;
&#x091c7;&#x07528;&#x08036;&#x09c81;-&#x05e03;&#x06717;&#x05f3a;&#x08feb;&#x091cf;&#x08868;&#x0ff08;YBOCS&#x0ff09;&#x05bf9;&#x060a3;&#x08005;&#x08fdb;&#x0884c;&#x08bc4;&#x04f30;&#x0ff1b;
&#x091c7;&#x07528;&#x091cd;&#x0590d;&#x06027;&#x0795e;&#x07ecf;&#x05fc3;&#x07406;&#x072b6;&#x06001;&#x06210;&#x05957;&#x06d4b;&#x09a8c;&#x0ff08;RBANS&#x0ff09;&#x05728;&#x08bd5;&#x09a8c;
&#x0524d;&#x0548c;8&#x05468;&#x0540e;&#x05bf9;&#x060a3;&#x08005;&#x08fdb;&#x0884c;&#x08bc4;&#x04f30;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x07814;&#x07a76;&#x07ec4;&#x06709;3&#x04f8b;&#x08131;&#x0843d;&#x0ff0c;&#x05bf9;&#x07167;&#x07ec4;&#x06709;4&#x04f8b;&#x08131;&#x0843d;&#x0ff08;<italic>&#x003c7;</italic><sup>2</sup>=0.186, 
<italic>p</italic>=0.712&#x0ff09;&#x03002;&#x05728;&#x07814;&#x07a76;&#x07ed3;&#x0675f;&#x065f6;&#x0ff0c;&#x07814;&#x07a76;&#x07ec4;37&#x04f8b;&#x04e2d;32&#x04f8b;&#x06cbb;
&#x07597;&#x06709;&#x06548;&#x0ff08;86.5&#x0ff05;&#x0ff09;&#x0ff0c;&#x05bf9;&#x07167;&#x07ec4;35&#x04f8b;&#x04e2d;22&#x04f8b;&#x06cbb;&#x07597;&#x06709;&#x06548;
&#x0ff08;62.9%&#x0ff09;&#x0ff08;<italic>&#x003c7;</italic><sup>2</sup>=5.36, <italic>p</italic>=0.021&#x0ff09;&#x03002;&#x091cd;&#x0590d;&#x06d4b;&#x091cf;&#x065b9;&#x05dee;&#x05206;&#x06790;
&#x08868;&#x0660e;&#x06cbb;&#x07597;6&#x05468;&#x065f6;&#x07814;&#x07a76;&#x07ec4;&#x05f3a;&#x08feb;&#x075c7;&#x075c7;&#x072b6;&#x07684;&#x06539;&#x05584;&#x0663e;&#x08457;&#x05927;&#x04e8e;
&#x05bf9;&#x07167;&#x07ec4;&#x03002;&#x08bd5;&#x09a8c;&#x07ed3;&#x0675f;&#x065f6;&#x0ff0c;&#x07814;&#x07a76;&#x07ec4;&#x060a3;&#x08005;&#x07684;RBANS&#x091cf;&#x08868;&#x06240;
&#x06709;5&#x04e2a;&#x07ef4;&#x05ea6;&#x07684;&#x08ba4;&#x077e5;&#x08bc4;&#x04f30;&#x05747;&#x0663e;&#x08457;&#x0597d;&#x04e8e;&#x05bf9;&#x07167;&#x07ec4;&#x0ff0c;&#x05e76;&#x04e14;&#x07814;&#x07a76;
&#x07ec4;YBOCS&#x08bc4;&#x05206;&#x07684;&#x053d8;&#x05316;&#x04e0e;RBANS&#x0603b;&#x05206;&#x07684;&#x053d8;&#x05316;&#x0663e;&#x08457;&#x076f8;&#x05173;
&#x0ff08;<italic>r</italic>=0.43, <italic>p</italic>=0.007&#x0ff09;&#x0ff0c;&#x04f46;&#x05728;&#x05bf9;&#x07167;&#x07ec4;&#x04e2d;&#x04e0d;&#x076f8;&#x05173;&#x0ff08;<italic>r</italic>=0.171, 
<italic>p</italic>=0.327&#x0ff09;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>&#x08be5;&#x09879;&#x065b9;&#x06cd5;&#x04e25;&#x08c28;&#x07684;&#x07814;&#x07a76;&#x08868;&#x0660e;&#x0ff0c;&#x05f3a;&#x08feb;&#x075c7;&#x060a3;&#x08005;&#x05728;&#x063a5;&#x053d7;
&#x0836f;&#x07269;&#x0548c;&#x05fc3;&#x07406;&#x06cbb;&#x07597;&#x07684;&#x0540c;&#x065f6;&#x08f85;&#x04ee5;8&#x05468;&#x07684;&#x08111;&#x07535;&#x0751f;&#x07269;&#x053cd;&#x09988;&#x08bad;&#x07ec3;
&#x053ef;&#x0663e;&#x08457;&#x06539;&#x05584;&#x04e34;&#x05e8a;&#x075c7;&#x072b6;&#x0548c;&#x08ba4;&#x077e5;&#x0529f;&#x080fd;&#x03002;&#x04eca;&#x0540e;&#x09700;&#x08981;&#x08fdb;&#x04e00;&#x06b65;&#x05f00;
&#x05c55;&#x05de5;&#x04f5c;&#x04ee5;&#x08bc4;&#x04f30;&#x0751f;&#x07269;&#x053cd;&#x09988;&#x08bad;&#x07ec3;&#x07684;&#x0957f;&#x0671f;&#x06548;&#x0679c;&#x0548c;&#x0521d;&#x059cb;&#x09636;&#x06bb5;&#x08bad;
&#x07ec3;&#x0540e;&#x05f3a;&#x05316;&#x08bad;&#x07ec3;&#x07684;&#x05fc5;&#x08981;&#x06027;&#x03002;</p></sec></trans-abstract><kwd-group kwd-group-type="author-created"><kwd>Obsessive compulsive disorder</kwd><kwd>EEG biofeedback</kwd><kwd>cognitive function</kwd><kwd>China </kwd></kwd-group><funding-group><award-group><funding-source country="CN">Jingzhou Science and Technology Development Plan</funding-source><award-id>2013AE39</award-id></award-group><funding-statement>This study was supported by the Jingzhou Science and 
Technology Development Plan (Grant No. 2013AE39).</funding-statement></funding-group></article-meta></front><body><sec id="s6"><label>1.</label><title>Background</title><p>
Obsessive-compulsive disorder (OCD) is a mental illness 
characterized by obsessive thoughts and (or) compulsive 
behaviors. Wide variations in the clinical presentations 
of OCD complicate the treatment of the condition 
and can result in a chronic course and poor prognosis. 
There are several treatment strategies for OCD, most 
of which combine medications with psychotherapy, 
but the clinical outcomes are often unsatisfactory.
<xref rid="B1" ref-type="bibr">[1]</xref>
Electroencephalograph (EEG) biofeedback is an adjunctive 
treatment to medications and psychotherapy that has 
proven beneficial in the treatment of panic disorders 
and other conditions.
<xref rid="B2" ref-type="bibr">[2]</xref>
It uses real-time EEG to promote 
desired brain activities and to suppress undesired brain 
activities. In this study, we tested the effectiveness 
of EEG biofeedback as an adjunctive treatment for 
cognitive-behavioral psychotherapy and medication in 
the treatment of OCD. </p></sec><sec sec-type="methods" id="s7"><label>2.</label><title>Methods</title><sec id="s7a"><label>2.1</label><title>Sample</title><p>
The enrollment process for the study is shown in Figure 
1. Potential participants were outpatients and inpatients 
seeking treatment at the Jingzhou Mental Health Center 
from May to December 2013 who met the following 
inclusion criteria: (a) 18 to 45 years of age; (b) junior high 
school education or above; (c) right-handed; (d) both 
the patient and the patient&#x02019;s guardian provided written 
informed consent to participate in the study; (e) met 
the International Classification of Diseases, 10<sup>th</sup> edition 
(ICD-10)
<xref rid="B3" ref-type="bibr">[3]</xref>
diagnostic criteria for obsessive-compulsive 
disorder based on a clinical examination conducted by 
an attending-level psychiatrist and confirmed by the 
department head; (f) had a score of &#x02265;18 on the YaleBrown Obsessive Compulsive Scale (YBOCS)
<xref rid="B4" ref-type="bibr">[4]</xref>
; and (g) 
had not taken any psychiatric medication in the two 
weeks prior to enrollment. The patients were excluded if 
they met any of the following exclusion criteria: (a) had 
a history of diabetes, high blood pressure, heart disease, 
diseases of the nervous system, substance dependence, 
schizophrenia, major depression, or other mental 
illnesses; (b) pregnant, breast feeding or planning to 
get pregnant; (c) experienced a recent physical trauma, 
surgery or acute or chronic infection; (d) color blind; or 
(e) serious suicidal ideation or behavior. </p><p>
After obtaining informed consent, 79 patients were 
randomized (using a random number table) into the 
study group (n=40) or the control group (n=39). There 
were 21 males and 19 females in the study group; 25 
(62.5%) were inpatients; their range of age was 18 to 43 
with a mean (sd) age of 26.7(8.2) years; their duration of 
disease was 0.5 to 13 years (mean [sd]= 3.8 [3.7] years, 
median=2.0 years); their mean (sd) age of onset was 
22.9 (5.0) years. There were 20 males and 19 females 
in the control group; 23 (58.9%) were inpatients; their 
range of age was 19 to 42 with a mean (sd) age of 26.6 
(7.8) years; the duration of disease was 0.6 to 12 years 
(mean [sd]= 3.7 [3.4] years, median=3.0 years); their 
mean (sd) age of onset was 23.0 (4.9) years. There 
were no statistically significant differences between the 
groups in gender, proportion of inpatients, age, duration 
of illness, or age of onset of illness.</p></sec><sec id="s7b"><label>2.2</label><title>Intervention</title><p>
Before the treatment began, patients who were taking 
medications at the time of enrollment underwent a 
two-week &#x02018;wash-out&#x02019; period. Among the 40 study group 
participants, 11 (27.5%) needed to participate in the 
2-week washout phase, and among the 39 control group participants, 9 (23.1%) required a washout period 
(<italic>&#x003c7;</italic><sup>2</sup>=0.15, <italic>p</italic>=0.698).</p><p>
During the following eight weeks, patients in both 
groups took sertraline 50 to 200mg/d. Among the 37 
participants in the study group who completed the 
study the mean (sd) dose was 168 (29) mg/d; among 
the 35 in the control group who completed the study 
the mean (sd) dose was 171 (30) mg/d. Patients did not 
take any other psychiatric medication during the 8-week 
trial. </p><p>
All patients also received 50 min cognitive-behavior 
therapy (CBT) sessions once a week for 8 weeks. CBT 
was conducted by four psychiatrists who graduated 
from a 3-year course in CBT and had more than 10 years 
of experience providing CBT. The specific procedures 
included: (a) establishing rapport with patients; (b) 
comprehensively understanding the patients&#x02019; specific 
psychological symptoms and requesting that they take 
daily notes about their &#x02018;automatic thoughts&#x02019;, emotional 
reactions and duration of symptoms; (c) analyzing 
symptoms with patients; and (d) helping the patients 
overcome maladaptive beliefs by engaging in objective 
and reasonable thinking.
<xref rid="B5" ref-type="bibr">[5]</xref></p><p>
The Biofeedback System Infinity 4000C, provided 
by Nanjing Vish Medical Technology Company, was used 
to treat the patients in the study group five times a 
week for eight weeks (a total of 40 times). Each session 
lasted 24 minutes. During the first session an operator 
explained the apparatus to the patient but after that 
patients had little contact with the operators (unless 
something unexpected occurred). At each session after 
being attached to the apparatus patients were given 
guided practice to help them master the techniques 
of relaxing and concentrating while observing their 
brainwaves. Based on the operation manual, patients 
were trained to increase specific types of brainwaves: &#x003b1;, 
sensorimotor rhythm (SMR), and &#x003b8; brainwaves.
<xref rid="B6" ref-type="bibr">[6]</xref>,<xref rid="B7" ref-type="bibr">[7]</xref></p></sec><sec id="s7c"><label>2.3</label><title>Assessments</title><p>
OCD symptoms were assessed using the YBOCS
<xref rid="B4" ref-type="bibr">[4]</xref>
at baseline and at the end of the 2<sup>nd</sup>
, 4<sup>th</sup>
, 6<sup>th</sup>
, and 8<sup>th</sup>
week of treatment. Patients&#x02019; cognitive functioning, 
was assessed using the Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS)
<xref rid="B8" ref-type="bibr">[8]</xref>
before the treatment and at the end of the 8<sup>th</sup>
week of 
treatment. Both the YBOCS and RBANS assessments 
were conducted by a psychiatrist with extensive 
experience in using the scales (from other research 
studies) who was blind to the group assignment of all 
patients. </p><p>
YBOCS is the most widely used assessment scale 
for OCD. The Chinese version of the YBOCS is reliable 
and valid and has been widely used in clinical studies 
and research.
<xref rid="B4" ref-type="bibr">[4]</xref>
The instrument has two parts &#x02013; a 
symptom checklist and a symptom severity measure. In 
the current study we only used the 10-item symptoms 
severity measure; the first five items assess the severity 
of obsessive thoughts and the second five items assess 
the severity of compulsive behaviors. Items are rated on 
a 0 to 4 Likert scale, thus the total score ranges from 0 
to 40 and the two subscale scores range from 0 to 20, 
with higher scores representing more severe symptoms. In this study we define &#x02018;improvement&#x02019; as a reduction of 
at least 50% in the baseline total YBOCS score.
<xref rid="B9" ref-type="bibr">[9]</xref></p><p>
A previous study has found that the Chinese version 
of the RBANS is reliable and valid.
<xref rid="B8" ref-type="bibr">[8]</xref><xref rid="B10" ref-type="bibr">[10]</xref>,
The battery 
includes 12 individual cognitive tasks assessing 5 cognitive 
domains: immediate memory/learning, visual spatial 
ability, language, attention, and delayed memory.
<xref rid="B11" ref-type="bibr">[11]</xref>,<xref rid="B12" ref-type="bibr">[12]</xref>
The 
sum of the 5 domain scores are combined into a total 
RBANS score, which provides an overall assessment of 
cognitive functioning.</p></sec><sec id="s7d"><label>2.4</label><title>Dropout criteria</title><p>
Patients were considered dropouts if: (a) they did not 
comply with the treatment regimen after enrollment; 
(b) they stopped the treatment due to serious adverse 
events, serious complications or special physiological 
changes; (c) they had to stop treatment due to physical 
diseases during the study; (d) their symptoms worsened 
and a change of treatment plan was needed; or (e) they 
dropped out voluntarily.</p></sec><sec id="s7e"><label>2.5</label><title>Statistical methods</title><p>
Data were double entered and analyzed using SPSS19.0. 
Continuous variables were analyzed using the repeated 
measures analysis of variance. Categorical variables 
were analyzed using chi-square tests. Correlations were 
estimated using the Pearson correlation coefficients. 
Significance level was set at 0.05 for all tests. All tests 
were two-tailed tests. The analytical sample consisted 
of all participants who completed the entire 8 weeks of 
treatment.</p></sec></sec><sec id="s8"><label>3</label><title>Results</title><p>
Based on the subscale ratings of the YBOCS at baseline, 
participants were subclassified as &#x02018;obsessive thought 
type&#x02019; (obsessive thought subscale score &#x0003e;5, compulsive 
behavior subscale score &#x0003c;5, and all compulsive item 
scores &#x0003c;2), &#x02018;compulsive behavior type&#x02019; (compulsive 
behavior subscale score &#x0003e;5, obsessive thought subscale 
score &#x02264;5, and all obsessive item scores &#x0003c;2), or &#x02018;mixed 
type&#x02019; (obsessive thoughts and compulsive behavior 
subscale scores both &#x0003e;5). The study group included 
13 patients classified as obsessive thought type, 3 
as compulsive behavior type, and 24 as mixed type; 
the control group included 12 patients classified as 
obsessive thought type, 4 as compulsive behavior type, 
and 23 as mixed type. The proportions of the three 
subtypes were not significantly different between the 
two groups (<italic>&#x003c7;</italic><sup>2</sup>=0.19,<italic>d&#x00192;</italic>=2, <italic>p</italic>=0.909).</p><sec id="s8a"><label>3.1</label><title>Completion of the trial and participation in the 
intervention</title><p>
As shown in Figure 1, 72 of the 79enrolled participants 
(91%) completed the 8-week trial. All 7 dropouts were 
participants who had been enrolled as outpatients. 
Three of the 40 participants (7.5%) in the study group 
and 4 of the 39 participants (10.3%) in the control group 
dropped out; the dropout rate was not significantly 
different between the two groups (<italic>&#x003c7;</italic><sup>2</sup>=0.19, <italic>p</italic>=0.666). 
Among the 48 participants who were inpatients at the 
time of enrollment &#x02013; all of whom completed the study 
&#x02013; 44 (91.7%) had been discharged and were being 
followed-up as outpatients at the time of the 8-week 
assessment.</p><fig id="sap-26-05-272-g002.tif" orientation="landscape" position="float"><label>Figure 1.</label><caption><title>Flowchart for the study</title></caption><graphic xlink:href="sap-26-05-272-g002"/></fig><p>
Attendance at the CBT group sessions was similar 
in the two groups: The 37 study-group patients and 
35 control-group patients who completed the study 
attended a mean (sd) of 7.92 (0.27) and 7.80 (0.41) 
of the 8 CBT groups sessions, respectively (<italic>t</italic>=1.45, 
<italic>p</italic>=0.149).</p><p>
In the study group, participation in the biofeedback 
sessions was also quite high: 24 of the 37 who completed 
the study attended all 40 sessions, 9 attended 39 
sessions, 1 attended 38 sessions, 1 attended 37 sessions, 
and 2 attended 36 sessions. Thus the overall attendance 
rate at the biofeedback sessions was 98.5%.</p></sec><sec id="s8b"><label>3.2</label><title>Comparison of the YBOCS scores in the two groups</title><p> 
As shown in Table 1, there was no difference in the 
YBOCS scores between the two groups at baseline 
(<italic>p</italic>=0.975). There was robust time main effect 
(<italic>F</italic>=2239.64, <italic>p</italic>&#x0003c;0.001) indicating that the YBOCS scores 
dropped over time. The overall group main effect was 
non-significant (<italic>F</italic>=2.30, <italic>p</italic>=0.314), but a group by time 
interaction was found (<italic>F</italic>=5.48, <italic>p</italic>=0.001). Therefore, 
post-hoc comparisons were carried out. At each followup (i.e., the end of the 2<sup>nd</sup>
, 4<sup>th</sup>
, 6<sup>th</sup>
, and 8<sup>th</sup>
weeks), the 
YBOCS scores dropped in both groups (<italic>p</italic>&#x0003c;0.01). But by 
the end of the 6<sup>th</sup>
and 8<sup>th</sup>
weeks, the drop in the study 
group was significantly greater than the drop in the 
control group (<italic>p</italic>=0.008 and 0.003, respectively).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Repeated measures analysis of variance comparison of the mean (sd) YBOCS total scores 
between the two groups before and after treatment </p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Study group<break/>(n=37)</th><th align="center" rowspan="1" colspan="1">Control group<break/>(n=35)</th><th align="center" rowspan="1" colspan="1"><italic>F</italic></th><th align="center" rowspan="1" colspan="1"><italic>d&#x00192;</italic></th><th align="center" rowspan="1" colspan="1"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Before treatment</td><td align="center" rowspan="1" colspan="1">25.22 (2.27)</td><td align="center" rowspan="1" colspan="1">25.20 (2.18)</td><td align="center" rowspan="1" colspan="1">0.00</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.975</td></tr><tr><td align="left" rowspan="1" colspan="1">End of the 2nd week</td><td align="center" rowspan="1" colspan="1">23.41 (2.54)</td><td align="center" rowspan="1" colspan="1">23.69 (2.58)</td><td align="center" rowspan="1" colspan="1">0.22</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.641</td></tr><tr><td align="left" rowspan="1" colspan="1">End of the 4th week</td><td align="center" rowspan="1" colspan="1">18.51 (2.64)</td><td align="center" rowspan="1" colspan="1">19.34 (2.60)</td><td align="center" rowspan="1" colspan="1">1.80</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.184</td></tr><tr><td align="left" rowspan="1" colspan="1">End of the 6th week</td><td align="center" rowspan="1" colspan="1">14.97 (2.10)</td><td align="center" rowspan="1" colspan="1">16.40 (2.35)</td><td align="center" rowspan="1" colspan="1">7.38</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"><bold>0.008</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">End of the 8th week</td><td align="center" rowspan="1" colspan="1">10.78 (1.20)</td><td align="center" rowspan="1" colspan="1">12.00 (2.03)</td><td align="center" rowspan="1" colspan="1">9.69</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"><bold>0.003</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Group main effect</td><td align="center" rowspan="1" colspan="1">---</td><td align="center" rowspan="1" colspan="1">---</td><td align="center" rowspan="1" colspan="1">2.30</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.134</td></tr><tr><td align="left" rowspan="1" colspan="1">Time main effect</td><td align="center" rowspan="1" colspan="1">---</td><td align="center" rowspan="1" colspan="1">---</td><td align="center" rowspan="1" colspan="1">2239.64</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Group<sup>*</sup> time interaction</td><td align="center" rowspan="1" colspan="1">---</td><td align="center" rowspan="1" colspan="1">---</td><td align="center" rowspan="1" colspan="1">5.48</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0.001</td></tr></tbody></table></table-wrap></sec><sec id="s8c"><label>3.3</label><title>Comparison of the treatment effects between the two groups</title><p>
Based on the criteria of a 50% drop from the baseline 
YBOCS score, at the end of the 8-week trial the 
treatment was effective in 32 of the 37 (86.5%) 
participants in the study group who completed the 
trial and in 22 of the 35 (62.9%) participants in the 
control group who completed the trial. The difference in 
effectiveness between the two groups was statistically 
significant (<italic>&#x003c7;</italic><sup>2</sup>=5.36, <italic>p</italic>=0.021).</p></sec><sec id="s8d"><label>3.4</label><title>Comparison of the RBANS scores of the two groups 
before and after the treatment</title><p>
As shown in Table 2, after 8 weeks of treatment, the 
group main effect was not statistically significant for 
three of the RBANS domains (immediate memory, visual 
spatial memory, and language) but it was statistically 
significant for the total RBANS scores and for the 
dimensions scores for attention and delayed memory. 
The time main effect and the group by time interactions 
were statistically significant for all five RBANS domains 
and for the total RBANS score. Post-hoc comparisons 
indicated statistically significant between-group 
differences in all five domains and in the total score; 
the improvement in scores for the study group were all 
greater than those for the control group.</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Repeated measures analysis of variance comparison of the mean (sd) YBOCS total scores 
between the two groups before and after treatment </p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Dimension</th><th align="left" rowspan="2" colspan="1">&#x000a0;</th><th align="center" rowspan="2" colspan="1">study group<break/>(n=37)</th><th align="center" rowspan="2" colspan="1">control group<break/>(n=35)</th><th align="center" colspan="2" rowspan="1">group<break/>main effect</th><th align="center" colspan="2" rowspan="1">time<break/>main effect</th><th align="center" colspan="2" rowspan="1">interaction<break/>effect</th></tr><tr><th align="center" rowspan="1" colspan="1"><italic>F</italic></th><th align="center" rowspan="1" colspan="1"><italic>p</italic></th><th align="center" rowspan="1" colspan="1"><italic>F</italic></th><th align="center" rowspan="1" colspan="1"><italic>p</italic></th><th align="center" rowspan="1" colspan="1"><italic>F</italic></th><th align="center" rowspan="1" colspan="1"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">immediate<break/>memory</td><td align="left" rowspan="1" colspan="1">before<break/>after<break/><italic>p</italic><sup>a</sup></td><td align="center" rowspan="1" colspan="1">61.22 (3.76)<break/>70.19 (2.99)<break/><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">62.03 (3.41)<break/>68.11 (4.21)<sup>b</sup><break/><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">0.329</td><td align="center" rowspan="1" colspan="1">181.19</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">6.66</td><td align="center" rowspan="1" colspan="1"><bold>0.012</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">visual spatial<break/>ability</td><td align="left" rowspan="1" colspan="1">before<break/>after<break/><italic>p</italic><sup>a</sup></td><td align="center" rowspan="1" colspan="1">70.97 (4.86)<break/>82.78 (4.21)<break/><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">70.91 (4.54)<break/>80.06 (3.15)<sup>b</sup><break/><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">2.26</td><td align="center" rowspan="1" colspan="1">0.137</td><td align="center" rowspan="1" colspan="1">753.15</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">12.21</td><td align="center" rowspan="1" colspan="1"><bold>0.001</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">language</td><td align="left" rowspan="1" colspan="1">before<break/>after<break/><italic>p</italic><sup>a</sup></td><td align="center" rowspan="1" colspan="1">75.22 (6.20)<break/>87.84 (3.70)<break/><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">75.80 (5.86)<break/>83.00 (8.34)<sup>b</sup><break/><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">3.69</td><td align="center" rowspan="1" colspan="1">0.059</td><td align="center" rowspan="1" colspan="1">106.37</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">7.96</td><td align="center" rowspan="1" colspan="1"><bold>0.006</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">attention</td><td align="left" rowspan="1" colspan="1">before<break/>after<break/><italic>p</italic><sup>a</sup></td><td align="center" rowspan="1" colspan="1">72.95 (3.81)<break/>80.78 (1.65)<break/><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">72.95 (3.81)<break/>77.14 (3.82)<sup>b</sup><break/><bold>&#x0003c;0.002</bold></td><td align="center" rowspan="1" colspan="1">6.34</td><td align="center" rowspan="1" colspan="1"><bold>0.014</bold></td><td align="center" rowspan="1" colspan="1">101.12</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">16.64</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">delayed<break/>memory</td><td align="left" rowspan="1" colspan="1">before<break/>after<break/><italic>p</italic><sup>a</sup></td><td align="center" rowspan="1" colspan="1">69.76 (3.76)<break/>81.65 (2.36)<break/><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">69.89 (3.73)<break/>78.69 (3.26)<sup>b</sup><break/><bold>&#x0003c;0.002</bold></td><td align="center" rowspan="1" colspan="1">5.09</td><td align="center" rowspan="1" colspan="1"><bold>0.027</bold></td><td align="center" rowspan="1" colspan="1">489.53</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">10.930</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">total score</td><td align="left" rowspan="1" colspan="1">before<break/>after<break/><italic>p</italic><sup>a</sup></td><td align="center" rowspan="1" colspan="1">62.19 (3.19)<break/>75.70 (2.21)<break/><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">62.69 (2.90)<break/>71.46 (2.49)<sup>b</sup><break/><bold>&#x0003c;0.002</bold></td><td align="center" rowspan="1" colspan="1">11.89</td><td align="center" rowspan="1" colspan="1"><bold>0.001</bold></td><td align="center" rowspan="1" colspan="1">1064.42</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td align="center" rowspan="1" colspan="1">148.20</td><td align="center" rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr></tbody></table><table-wrap-foot><fn><p>RBANS, Repeatable Battery for the Assessment of Neuropsychological Status</p><p>
<sup>a</sup> p-value for the before-after comparison within the group</p><p>
<sup>b</sup> F-test for the between-group comparisons: immediate memory (<italic>F</italic>=6.66, <italic>p</italic>=0.012), visual spatial ability (<italic>F</italic>=12.21, <italic>p</italic>=0.001), language 
(<italic>F</italic>=7.96, <italic>p</italic>=0.006), attention (<italic>F</italic>=16.64, <italic>p</italic>&#x0003c;0.001), delayed memory (<italic>F</italic>=10.93, <italic>p</italic>=0.001), and total score (<italic>F</italic>=48.20, <italic>p</italic>&#x0003c;0.001)</p></fn></table-wrap-foot></table-wrap></sec><sec id="s8e"><label>3.5</label><title>Correlation analysis of the improvement of symptoms and cognitive functions of the two groups</title><p>
At the end of 8<sup>th</sup>
week, changes in the YBOCS score were 
significantly correlated with changes in the RBANS total 
score in the study group (<italic>r</italic>&#x0003c;0.433, <italic>p</italic>=0.007) but this 
correlation was much weaker (and non-significant) in 
the control group (<italic>r</italic>&#x0003c;0.17, <italic>p</italic>=0.327).</p></sec></sec><sec id="s9"><label>4</label><title>Discussion</title><sec id="s9a"><label>4.1</label><title>Main findings</title><p> 
This randomized controlled trial with a blind evaluation 
of the outcome provided clear evidence that adjunctive 
treatment with EEG biofeedback can improve the 
treatment effect of standard treatment with medication 
and psychotherapy for OCD. Over an 8-week treatment 
trial the greater improvement in OCD symptoms in the 
group that had adjunctive treatment with biofeedback 
became statistically significant by the end of the 6<sup>th</sup>
week. We also found that patients who received 
adjunctive treatment with EEG-based biofeedback 
show significantly greater improvement in cognitive 
functioning after 8 weeks of treatment, an improvement 
that was strongly correlated with the improvement in 
OCD symptoms.</p><p>
These findings are consistent with previous reports 
by both Western
<xref rid="B13" ref-type="bibr">[13]</xref>
and Chinese
<xref rid="B14" ref-type="bibr">[14]</xref>
researchers who also 
find that EEG biofeedback is effective in improving the 
symptoms of OCD. Patients with OCD have elevated 
levels of anxiety, which can induce psychological and 
physical changes such as tension, changes in brain 
waves, and elevated heart rate and blood pressure. 
EEG biofeedback is a technique that helps individuals 
understand these physical changes (which they are 
usually not aware of before the training). It also helps 
them learn how to regulate these psychological and 
physical changes. As they master these relaxation skills 
there is a corresponding improvement in the symptoms 
of OCD. However, the etiology of OCD remains 
unclear,
<xref rid="B15" ref-type="bibr">[15]</xref>
so further research will be needed to clarify 
the exact mechanisms via which biofeedback augments 
the treatment effects of medication and psychotherapy.</p><p>
Cognitive functioning is closely associated with 
the clinical presentation of OCD and with the shortterm and long-term prognosis for OCD.
<xref rid="B16" ref-type="bibr">[16]</xref>,<xref rid="B17" ref-type="bibr">[17]</xref> 
Despite 
recent increased research interest in the cognitive 
functioning of individuals with OCD, few studies have 
assessed the effects of biofeedback on cognitive 
functioning in OCD patients. One exception is a study 
by Liu and colleagues
<xref rid="B18" ref-type="bibr">[18]</xref>
who reported that providing 
EEG biofeedback training to patients with OCD can 
improve their cognitive functioning as assessed by the 
Cancellation Test, the Clinical Memory Scale, and the 
Wisconsin Card Sorting Test.<xref rid="B19" ref-type="bibr">[19]</xref>,<xref rid="B20" ref-type="bibr">[20]</xref>
In the current study 
we expanded on these results; our use of the RBANS, 
a multi-dimensional assessment tool of cognitive 
functioning, provided evidence about the benefit 
of biofeedback in OCD for two additional cognitive 
domains not considered in previous studies &#x02013; visual 
spatial ability and language. Furthermore, we also found 
that the improvement in cognitive function associated 
with EEG biofeedback was closely correlated with 
improvement in OCD symptoms. </p></sec><sec id="s9b"><label>4.2</label><title>Limitations</title><p>
Several limitations should be borne in mind when 
interpreting findings from this study. First, there was no 
placebo control of the EEG biofeedback therapy (e.g., 
mock EEG training) so it is possible that the improved 
OCD symptoms and cognitive functioning was due to 
the &#x02018;placebo effect&#x02019; of the 40 additional contacts with 
clinicians individuals in the study group experienced 
over the 8-week trial (i.e., unrelated to the EEG 
biofeedback training). Second, the two-week &#x02018;washout&#x02019; 
period for patients who were being medicated at the 
time of enrollment in the study may have aggravated 
OCD symptoms and cognitive dysfunction due to 
withdrawal from medications, though this potential 
effect would have been similar in the two groups. Third, 
the small sample size precluded stratified analysis by 
types of OCD or other factors. Fourth, the inclusion 
of both inpatients and outpatients in the study and 
the change of some participants from inpatient to 
outpatient status during the study (i.e., differences in 
the settings in which they are living and being evaluated 
in) was a confounding variable that was not adequately 
controlled for. Fifth, it would have been better to 
conduct an &#x02018;intention to treat&#x02019; analysis by carrying 
the final results of the 7 dropout patients forward, 
but, given the small number of dropouts, this would 
not significantly affect the overall findings. And finally, 
due to the lack of Chinese norms, we cannot compare 
the RBANS cognitive functioning scores of the OCD 
participants to those of the general Chinese population. 
Future studies are needed to address these issues 
and to determine whether the short-term benefits of 
biofeedback training persist over the long-term, after 
the training has stopped.</p></sec><sec id="s9c"><label>4.3</label><title> Implications</title><p>
This study had a reasonably sized sample (n=79), and 
used a randomized controlled design, a blind evaluation 
of outcome, and standardized assessment measures. 
Given the methodological strength of the study, the 
unequivocal result that 8 weeks of adjunctive treatment 
with EEG biofeedback enhances the improvement 
in OCD symptoms and cognitive functioning of 
OCD patients being treated with medication and 
psychotherapy is quite robust. But the intervention is 
quite intensive &#x02013; requiring daily sessions for the patients 
&#x02013; so additional work is needed to determine whether 
or not the benefit persists after stopping the training 
sessions and, if not, the frequency of booster sessions 
that are needed to maintain the beneficial effects. </p></sec></sec></body><back><fn-group><fn><p>Conflict of interest: The authors report no conflict of interest related to this 
manuscript.</p></fn></fn-group><fn-group><fn><p>Ethical review: The study was approved by the research review committee of the Jingzhou Mental Health Center. </p></fn></fn-group><fn-group><fn><p>Informed consent: Written informed consent was obtained from all participants and their family members. </p></fn></fn-group><bio id="d35e38"><p><graphic xlink:href="sap-26-05-272-g001.gif" position="float" orientation="portrait"/></p><p>Xiaopeng Deng graduated from China Three Gorges University, in Hubei in 2003. He is currently 
pursuing his Master&#x02019;s degree at Wuhan University. He is an attending psychiatrist at Hubei Jingzhou 
Mental Health Center and Director of the Medical department. He is interested in biological psychiatry 
and social psychiatry.</p></bio><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XM</given-names></name><name><surname>Xiao</surname><given-names>ZP</given-names></name></person-group><article-title>[The treatment and progress of OCD]</article-title><source>Zhonghua Xing Wei Yi Xue Yu Nao Ke Xue Za Zhi</source><year>2009</year><volume>18</volume><issue>1</issue><fpage>1054</fpage><lpage>1056</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.3760/cma.j.issn.1674-6554.2009.11.036</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zhen</surname><given-names>YP</given-names></name></person-group><source>[Clinical Practice of Biofeedback]</source><publisher-loc>Beijing</publisher-loc><publisher-name>Higher Education Press</publisher-name><year>2003</year><fpage>15</fpage><lpage>30</lpage><comment>Chinese</comment></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>XD</given-names></name></person-group><source>[ICD-10 Classification of Mental and Behavioral Disorders, Clinical Descriptions and Diagnostic Criteria]</source><publisher-loc>Beijing</publisher-loc><publisher-name>People&#x02019;s Health Publishing House</publisher-name><year>1993</year><fpage>116</fpage><lpage>118</lpage><comment>Chinese</comment></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>HY</given-names></name></person-group><article-title>[The reliability and validy of the Chinese version of Yale-Brown obsessive-compulsive scale]</article-title><source>Shanghai Arch Psychiatry</source><year>2006</year><volume>18</volume><issue>6</issue><fpage>321</fpage><lpage>323</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.3969/j.issn.1002-0829.2006.06.001</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>QY</given-names></name><name><surname>Wang</surname><given-names>BL</given-names></name><name><surname>Kong</surname><given-names>LL</given-names></name><name><surname>Wang</surname><given-names>WF</given-names></name></person-group><article-title>[Analysis of Duloxetine 
combined cognitive behavioral therapy in patients with 
somatoform disorders]</article-title><source>Jing Shen Yi Xue Za Zhi</source><year>2003</year><volume>26</volume><issue>3</issue><fpage>169</fpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.3969/j.issn.1009-7201.2013.03.003</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>YK</given-names></name></person-group><source>[Clinical Electroencephalography]</source><publisher-loc>Beijing</publisher-loc><publisher-name>People&#x02019;s Health Publishing House</publisher-name><year>1980</year><fpage>11</fpage><lpage>19</lpage><comment>Chinese</comment></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>O</given-names></name><name><surname>Feng</surname><given-names>XM</given-names></name><name><surname>Zhou</surname><given-names>ZQ</given-names></name><name><surname>Guo</surname><given-names>ZX</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name></person-group><article-title>[Clinical studies of biofeedback therapy on anxiety disorder after brain stroke]</article-title><source>Zhongguo Liao Yang Yi Xue</source><year>2012</year><volume>21</volume><issue>3</issue><fpage>252</fpage><lpage>253</lpage><comment>Chinese</comment></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>BH</given-names></name><name><surname>Tan</surname><given-names>YL</given-names></name><name><surname>Zhang</surname><given-names>WF</given-names></name><name><surname>Eang</surname><given-names>ZR</given-names></name><name><surname>Yang</surname><given-names>GG</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><etal/></person-group><article-title>[Repeatable battery for the assessment of neuropsychological status as a screening test in Chinese]</article-title><source>Zhongguo Xin Li Wei Sheng Za Zhi</source><year>2008</year><volume>22</volume><issue>12</issue><fpage>866</fpage><lpage>867</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.3321/j.issn:1000-6729.2008.12.001</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ZS</given-names></name><name><surname>Cui</surname><given-names>MH</given-names></name><name><surname>Song</surname><given-names>XL</given-names></name><name><surname>Lin</surname><given-names>XY</given-names></name></person-group><article-title> ZS, Cui MH, XL, XY. [Curative effect analysis of 
comprehensive psychotherapy in the treatment of refractory obsessive compulsive disorder]</article-title><source>Bingzhou Yi Xue Yuan Xue Bao</source><year>2014</year><volume>2</volume><issue>37</issue><fpage>19</fpage><lpage>20</lpage><comment>Chinese</comment></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JH</given-names></name><name><surname>Li</surname><given-names>CB</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Yi</surname><given-names>ZH</given-names></name><name><surname>Long</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name></person-group><article-title>[Reliability and validity of repeatable battery for the 
assessment of neuropsychological status (RBANS)]</article-title><source>Shanghai Arch Psychiatry</source><year>2009</year><volume>21</volume><issue>5</issue><fpage>265</fpage><lpage>268</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.3969/j.issn.1002-0829.2009.05.003</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>CY</given-names></name><name><surname>Sha</surname><given-names>WW</given-names></name><name><surname>Zhang</surname><given-names>XB</given-names></name><name><surname>Geng</surname><given-names>DQ</given-names></name><name><surname>Dong</surname><given-names>XX</given-names></name><name><surname>Fang</surname><given-names>CL</given-names></name></person-group><article-title>[Evaluation of cognitive functions and its influencing factors 
in refractory obsessive-compulsive disorder]</article-title><source>Lin Chuang Jing Shen Yi Xue Za Zhi</source><year>2011</year><volume>21</volume><issue>6</issue><fpage>391</fpage><comment>Chinese</comment></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>WH</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Long</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Yi</surname><given-names>ZH</given-names></name></person-group><article-title>[A comparative 
study of the effect of rTMS on cognitive function in patients 
with chronic schizophrenia]</article-title><source>Jing Shen Yi Xue</source><year>2013</year><volume>26</volume><issue>2</issue><fpage>104</fpage><comment>Chinese</comment></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarov</surname><given-names>A</given-names></name><name><surname>Dar</surname><given-names>R</given-names></name><name><surname>Oded</surname><given-names>Y</given-names></name></person-group><article-title>Are obsessive compulsive 
tendencies related to reliance on external proxies for 
internal states Evidence from biofeedback-aided relaxation studies</article-title><source>Behav Res Ther</source><year>2010</year><volume>48</volume><fpage>516</fpage><lpage>523</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.1016/j.brat.2010.02.007</pub-id><pub-id pub-id-type="pmid">20303473</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>An</surname><given-names>CX</given-names></name><name><surname>Wang</surname><given-names>XY</given-names></name></person-group><article-title>[Impact of the biofeedback technology on OCD psychological and physiological parameters]</article-title><source>Zhongguo Jian Kang Xin Li Xue Za Zhi</source><year>2010</year><volume>18</volume><issue>5</issue><fpage>513</fpage><lpage>515</lpage><comment>Chinese</comment></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>HD</given-names></name></person-group><article-title>[OCD brain dysfunction]</article-title><source>Xin Li Ke Xue Jin Zhan</source><year>2006</year><volume>14</volume><issue>3</issue><fpage>401</fpage><lpage>407</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.3760/cma.j.issn.1674-6554.2009.11.036</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantella</surname><given-names>RC</given-names></name><name><surname>Butters</surname><given-names>MA</given-names></name><name><surname>Dew</surname><given-names>MA</given-names></name><name><surname>Mulsant</surname><given-names>BH</given-names></name><name><surname>Begley</surname><given-names>A</given-names></name><name><surname>Tracey</surname><given-names>B</given-names></name><etal/></person-group><article-title>Cognitive impairment in late-life generalized anxiety disorder</article-title><source>Am J Geriatr Psychiatry</source><year>2007</year><volume>15</volume><issue>8</issue><fpage>673</fpage><lpage>679</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.1097/JGP.0b013e31803111f2</pub-id><pub-id pub-id-type="pmid">17426260</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Addington</surname><given-names>J</given-names></name><name><surname>Girard</surname><given-names>TA</given-names></name><name><surname>Christeneen</surname><given-names>BK</given-names></name><name><surname>Addington</surname><given-names>D</given-names></name></person-group><article-title>Social 
cognition mediates illness related and cognitive influences 
social function in patients with schizophrenia&#x000b7;spectrum 
disorders</article-title><source>J Psychiatry Neurosci</source><year>2010</year><volume>35</volume><issue>1</issue><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1503/jpn.080039</pub-id><pub-id pub-id-type="pmid">20040246</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>GJ</given-names></name><name><surname>Chen</surname><given-names>XS</given-names></name><name><surname>Chen</surname><given-names>MY</given-names></name></person-group><article-title>[The study of eeg biofeedback treatment improving cognitive function in obsessive compulsive disorder]</article-title><source>Xian Dai Zhen Duan Yu Zhi Liao</source><year>2012</year><volume>23</volume><issue>1</issue><fpage>15</fpage><lpage>16</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.3969/j.issn.1001-8174.2012.01.006</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>YF</given-names></name><name><surname>Zhang</surname><given-names>YL</given-names></name><name><surname>Hu</surname><given-names>JZ</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>ZF</given-names></name><name><surname>Li</surname><given-names>HZ</given-names></name></person-group><article-title> [A preliminary study of cognitive dysfunction in obsessivecompulsive disorder]</article-title><source>Zhongguo Lin Chuang Xin Li Xue Za Zhi</source><year>2005</year><volume>13</volume><issue>3</issue><fpage>337</fpage><lpage>339</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.3969/j.issn.1005-3611.2005.03.029</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JR</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>HX</given-names></name></person-group><article-title>[A study of cognitive feature in first-episode patients with obsessive-compulsive 
disorder]</article-title><source>Jing Shen Yi Xie Za Zhi</source><year>2009</year><volume>22</volume><issue>2</issue><fpage>98</fpage><lpage>99</lpage><comment>Chinese</comment><pub-id pub-id-type="doi">10.3969/j.issn.1009-7201.2009.02.006</pub-id></element-citation></ref></ref-list></back></article>